Maria Sharapova accepts she will have a cloud of suspicion hanging over her when she returns to tennis next month.
The five-time grand slam champion is serving a 15-month doping ban after testing positive for meldonium at the Australian Open in 2016.
Sharapova's suspension runs out on April 26, and she will play her first match the same day, having been given a wildcard into the Porsche Grand Prix in Stuttgart.
The Russian's impending return is the hottest topic in tennis, with the reaction from her fellow players largely lukewarm.
The awarding of a wildcard for a tournament that begins while she is still banned has been particularly controversial, with Caroline Wozniacki branding it "disrespectful".
News that makes sense
Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.
The French Open and Wimbledon, meanwhile, are under pressure over whether to award entry to the former champion.
Sharapova admitted taking meldonium at an extraordinary press conference last March, insisting her only mistake was not realising the drug had been added to the banned list at the start of 2016.
An initial two-year ban was reduced to 15 months on appeal to the Court of Arbitration for Sport, which concluded she had not intended to cheat.
Asked if she expected the suspicion to linger for the rest of her career, Sharapova told Vogue: "I think if I was trying to hide something, I don't think I would come out to the world and say I was taking a drug for 10 years.
"If I was really trying to take the easy way out, that's not a very smart thing to do. But the answer to your question is, absolutely."
Sharapova is more confident of the reception she will receive from the public.
The 29-year-old, one of tennis' biggest stars and the world's highest-earning female athlete, got a taste of life after the ban at exhibition matches in Las Vegas and Puerto Rico late last year.
"I received really nice receptions when I walked out to play my exhibition matches," she said.
